1 P. Ungprasert, A. Tooley, C. Crowson, et al.Clinical characteristics of ocular sarcoidosis: a population-based study 1976-2013 Ocul Immunol Inflamm, 27 (3) (2019), pp. 389-395, 10.1080/09273948.2017.1386791

2 C. Obenauf, H. Shaw, C. Sydnor, et al.Sarcoidosis and its ophthalmic manifestations Am J Ophthalmol, 86 (5) (1978), pp. 648-655, 10.1016/0002-9394(78)90184-8

3 M. Dana, J. Merayo-Lloves, D. Schaumberg, et al.Prognosticators for visual outcome in sarcoid uveitis Ophthalmology, 103 (11) (1996), pp. 1846-1853, 10.1016/s0161-6420(96)30417-x

4 M. Iannuzzi, B. Rybicki, A. Teirstein, et al.Sarcoidosis N Engl J Med, 357 (21) (2007), pp. 2153-2165, 10.1056/NEJMra071714

5 R. Baughman, A. Teirstein, M. Judson, et al.Clinical characteristics of patients in a case control study of sarcoidosis Am J Respir Crit Care Med, 164 (10 Pt 1) (2001), pp. 1885-1889, 10.1164/ajrccm.164.10.2104046

6 Y. Hsu, J. Huang, Y. Tao, et al.Noninfectious uveitis in the Asia-Pacific region Eye, 33 (1) (2019), pp. 66-77, 10.1038/s41433-018-0223-z

7 L. Siltzbach, D. James, E. Neville, et al.Course and prognosis of sarcoidosis around the world Am J Med, 57 (6) (1974), pp. 847-852, 10.1016/0002-9343(74)90160-0

8 K. Nagata, K. Maruyama, S. Sugita, et al.Age differences in sarcoidosis patients with posterior ocular lesions Ocul Immunol Inflamm, 22 (4) (2014), pp. 257-262, 10.3109/09273948.2013.855796

9 C. Herbort, M. Rao NMochizukiInternational criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop on Ocular Sarcoidosis (IWOS) Ocul Immunol Inflamm, 17 (3) (2009), pp. 160-169, 10.1080/09273940902818861

10 M. Mochizuki, J. Smith, H. Takase, et al.Revised criteria of international Workshop on ocular sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis Br J Ophthalmol, 103 (10) (2019), pp. 1418-1422, 10.1136/bjophthalmol-2018-313356

11 X. Cao, X. Wang HPeng[Clinical characteristics of patients with biopsy-proven sarcoid uveitis] Zhonghua Yixue Zazhi, 100 (32) (2020), pp. 2498-2502, 10.3760/cma.j.cn112137-20200426-01323

12 M. Iannuzzi, A. Rybicki BTeirsteinSarcoidosis N Engl J Med, 357 (21) (2007), pp. 2153-2165, 10.1056/NEJMra071714

13 P. Ungprasert, E. Carmona, C. Crowson, et al.Diagnostic utility of angiotensin-converting enzyme in sarcoidosis: a population-based study Lung, 194 (1) (2016), pp. 91-95, 10.1007/s00408-015-9826-3

14 S. Hwang DSheuAn update on the diagnosis and management of ocular sarcoidosis Curr Opin Ophthalmol, 31 (6) (2020), pp. 521-531, 10.1097/icu.0000000000000704

15 A. Liu DBirnbaumUpdate on sarcoidosis Curr Opin Ophthalmol, 26 (6) (2015), pp. 512-516, 10.1097/icu.0000000000000207

16 S. Dhont, M. Leys, E. De Sutter, et al.Uveitis as a window to diagnosis of sarcoidosis - case report and review of the literature Acta Clin Belg, 75 (4) (2020), pp. 245-249, 10.1080/17843286.2019.1613309

17 D. Jabs, J. Nussenblatt RRosenbaumStandardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop Am J Ophthalmol, 140 (3) (2005), pp. 509-516, 10.1016/j.ajo.2005.03.057

18 H. TakaseCharacteristics and management of ocular sarcoidosis Immunol Med (2021), pp. 1-10, 10.1080/25785826.2021.1940740

19 M. DurandBacterial and fungal endophthalmitis Clin Microbiol Rev, 30 (3) (2017), pp. 597-613, 10.1128/cmr.00113-16

20 H. Zhuang, X. Ding, F. Gao, et al.Optical coherence tomography features of retinal lesions in Chinese patients with endogenous Candida endophthalmitis BMC Ophthalmol, 20 (1) (2020), p. 52, 10.1186/s12886-020-01337-9

21 S. Güngör, I. Akkoyun, N. Reyhan, et al.Choroidal thickness in ocular sarcoidosis during quiescent phase using enhanced depth imaging optical coherence tomography Ocul Immunol Inflamm, 22 (4) (2014), pp. 287-293, 10.3109/09273948.2014.920034

22 M. Sadiq, M. Hassan, A. Agarwal, et al.Endogenous endophthalmitis: diagnosis, management, and prognosis J Ophthal Inflam Infect, 5 (1) (2015), p. 32, 10.1186/s12348-015-0063-y

23 T. Sato, R. Kinoshita, M. Taguchi, et al.Assessment of diagnostic and therapeutic vitrectomy for vitreous opacity associated with uveitis with various etiologies Medicine, 97 (2) (2018), Article e9491, 10.1097/md.0000000000009491

24 A. RothovaOcular involvement in sarcoidosis Br J Ophthalmol, 84 (1) (2020), pp. 110-116, 10.1136/bjo.84.1.110

25 H. Takase, N. Acharya, K. Babu, et al.Recommendations for the management of ocular sarcoidosis from the international Workshop on ocular sarcoidosis Br J Ophthalmol, 105 (11) (2021), pp. 1515-1519, 10.1136/bjophthalmol-2020-317354

26 J. ReichCorticosteroid therapy and relapse in sarcoidosis Chest, 113 (2) (1998), pp. 559-561, 10.1378/chest.113.2.559-b

27 E. Baughman RLowerTreatment of sarcoidosis Clin Rev Allergy Immunol, 49 (1) (2015), pp. 79-92, 10.1007/s12016-015-8492-9